1. Dadeko A.V. Photophysical properties of Dimegin as a photosensitizer for photodynamic therapy and fluorescence diagnostics. Abstract of the dissertation thesis of Candidate of Physical and Mathematical Sciences. Saint Petersburg; 2018. [In Russ.].
2. Kozel N.V., Shalygo N.V. A technique for assessing the photosensitizer phototoxicity. Patent for invention BY 15504 C1, 28.02.2012. Application N 20081283 dated 13.10.2008. [In Russ.].
3. Yakubovskaya R.I., Plyutinskaya A.D., Lukyanets E.A. Comparative study of photosensitizers of different classes in an in vitro system. Phthalocyanines. Rossiyskiy bioterapevticheskiy zhurnal. 2014. 13 (4): 65–72. [In Russ.].
4. Makarova E.A., Yakubovskaya R.I., Vorozhtsov G.N., Lastovoy A.P., Lukyanets E.A., Morozova N.B., Plotnikova E.A. Photosensitizer for photodynamic therapy. Patent for invention RU 2549953 C2, 05.10.2015. Application N 2013157611/15 dated 25.12.2013. [In Russ.].
5. Bondarenko V.M., Alekseev Yu.V., Mislavsky O.V., Ponomarev G.V. Prospects for the application of 2,4-di(1- methoxyethyl)-deuteroporphyrin-IX (“dimegin”) disodium salt for photodynamic therapy of non-oncological diseases. Biomeditsinskaya khimiya. 2014; 60 (3): 338–347. [In Russ.].